Maternal serum and umbilical cord tumor marker levels at term pregnancy

References

• Schutter EM, Davelaar EM, van Kamp GJ, Verstraeten RA, Kenemans P, Verheijen RH. The differential diagnostic potential of a panel of tumor markers (CA 125, CA 15–3, and CA 72–4 antigens) in patient with a pelvic mass. Am J Obstet Gynecol 2002; 187: 385–92.
   PubMed Web of Science ®Google Scholar
• Tietz NW. Clinical Guide to Laboratory Tests, 3rd edn. Philadelphia: W.B. Saunders Company, 1995: 106–15.
   Google Scholar
• Engelen MJA, de Bruijn HWA, Hollema H, ten Hoor KA, Willemse PHB, Aalders JG et al. Serum CA 125, carcinoem- bryonic antigen, and CA 19–9 as tumor markers in borderline ovarian tumors. Gynecol Oncol 2000; 78: 16–20.
   PubMed Web of Science ®Google Scholar
• Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC III, Hauth JC, Wenstram KD. Growth and Development. Williams Obstetrics 21st International ed. XXXX: McGraw Hill Co., 2001: 138.
   Google Scholar
• Panidis D, Vlassis G, Matalliotakis J, Skiadopoulos S, Kalogeropoulos A. Serum levels of the oncofetal antigens CA 125, CA 19–9 and CA 15–3 in patients with endometriosis. J Endocrinol Invest 1988; 11: 801–4.
   Google Scholar
• Kobayashi F, Sagawa N, Nanbu Y, Nakamura K, Nonogaki M, Ban C, et al. Immunohistochemical localization and tissue levels of tumor-associated glycoproteins CA 125 and CA 19–9 in the decidua and fetal membranes at various gestational ages. Am J Obstet Gynecol 1989; 160: 1232–8.
   PubMed Web of Science ®Google Scholar
• Hohlfeld P, Dang TT, Nahoul K, Daffos F, Forestier F. Tumour-associated antigens in maternal and fetal blood. Prenatal Diagnosis 1994; 14: 907–12.
   PubMed Web of Science ®Google Scholar
• Tayyar M, Tutus A. The effect of maternal age, parity, and fetal sex on the amniotic fluid and maternal serum levels of CA 125, CA 19.9, CA 15.3, CEA. Int J Fertil 1999; 44: 256–9.
   Google Scholar
• Botsis D, Sarandakou A, Kassanos D, Kontoravdis A, Rizos D, Protonotariou E et al. Breast cancer markers during normal pregnancy. Anticancer Res 1999; 19: 3539–42.
   PubMed Web of Science ®Google Scholar
• Lahdenne P, Pitkanen S, Rajantie J, Kuusela P, Siimes MA, Lanning M et al. Tumor markers CA 125 and CA 19–9 in cord blood and during infancy: developmental changes and use in pediatric germ cell tumors. Pediatr Res 1995; 38: 797–801.
   PubMed Web of Science ®Google Scholar
• O’Brien TJ, Hardin JW, Bannon GA, Norris JS, Quirk JG Jr. CA 125 antigen in human amniotic fluid and fetal membranes. Am J Obstet Gynecol 1986; 155: 50–5.
   Google Scholar
• Spitzer M, Kaushal N, Benjamin F. Maternal CA-125 levels in pregnancy and the puerperium. J Reprod Med 1998; 43: 387–92.
   Google Scholar
• Norman-Taylor JQ, Woolas RP, Oram DH, Grudzinskas JG. Serum CA 125 in a pregnancy generated by ovum donation. Hum Reprod 1994; 9: 147–8.
   Google Scholar
• Lellé RJ, Henkel E, Leinemann D, Goeschen K. Measurement of CEA, TPA, Neopterin, CA 125, CA 153 and CA 199 in sera of pregnant women, umbilical cord blood and amniotic fluid. Gynecol Obstet Invest 1989; 27: 137–42.
   Google Scholar
• Schlageter MH, Larghero J, Cassinat B, Toubert ME, Borschneck C, Rain JD. Serum carcinoembryonic antigen, cancer antigen 125, cancer antigen 15–3, squamous cell carcinoma, and tumor-associated trypsin inhibitor concentrations during healthy pregnancy. Clin Chem 1998; 44: 1995–8.
   PubMed Web of Science ®Google Scholar
• Cheli CD, Morris DL, Neaman IE, Dai J, Allard WJ, Yeung KK. Measurement of four tumor marker antigens in the sera of pregnant women. J Clin Laboratory Anal 1999; 13: 35–9.
   PubMed Web of Science ®Google Scholar
• Gould DA, Moscoso GJ, Young MPA, Barton DPJ. Human first trimester fetal ovaries express oncofetal antigens and steroid receptors. J Soc Gynecol Invest 2000; 7: 131–8.
   PubMedGoogle Scholar
• Sarandakou A, Kontoravdis A, Kontogeorgi Z, Rizos D, Phocas I. Expression of CEA, CA 125 and SCC antigen by biological fluids associated with pregnancy. Eur J Obstet Gynecol Reprod Biol 1992; 44: 215–20.
   Google Scholar